One study showed decreased levels of insulin-like growth factor binding protein-2 (IGBP-2) and increased levels of insulin-like growth factor 1 receptor (IGF-1R) in the temporal cortex of AD patients [83]. Here, IGF1R is linked to Alzheimer disease.